You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Exjade

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease Trial in Amsterdam (Deferasirox 360 MG)

Recruiting
  • Sickle Cell Disease
  • Deferasirox 360 MG
  • Amsterdam, Meibergdreef 9, Netherlands
    Amsterdan UMC location AMC
May 23, 2022

Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))

Completed
Has Results
  • Thalassemia
  • Iron Overload
  • Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
  • Oakland, California
    CHRCO
Jul 20, 2021

Thalassemia Major Trial in New York, Bangkok, Chiang Mai (DST-0509, Jadenu, Exjade)

Completed
  • Thalassemia Major
  • New York, New York
  • +3 more
Jan 31, 2022

Measures to Prevent Liver and Pancreas Complications in

Active, not recruiting
  • Iron Overload
  • Trieste, Italy
    IRCCS Burlo Garofolo
Jan 4, 2022

MDS Trial in Erlangen (Deferasirox (Novartis Pharma))

Terminated
Has Results
  • Myelodysplastic Syndromes
  • Deferasirox (Novartis Pharma)
  • Erlangen, Bavaria, Germany
    Medizinische Klinik 5, Universitätsklinikum Erlangen
Sep 11, 2020

Transfusional Iron Overload, Iron Overload, Iron Chelation Trial (SPD602, Deferasirox)

Withdrawn
  • Transfusional Iron Overload
  • +6 more
  • (no location specified)
Jun 1, 2021

High Risk MDS or AML Patients Trial in Philadelphia (Exjade® (deferasirox, ICL670))

Completed
  • High Risk MDS or AML Patients
  • Exjade® (deferasirox, ICL670)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 7, 2020

Anemia, Myelodysplastic Syndrome Trial in Seattle (Deferasirox, Laboratory Biomarker Analysis)

Terminated
Has Results
  • Anemia
  • Myelodysplastic Syndrome
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 12, 2020

Acute Myeloid Leukemia Trial in Maywood (Deferasirox, Cholecalciferol, Azacitidine)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Maywood, Illinois
    Loyola University Cardinal Bernardin Cancer Center
Feb 25, 2020

Aplastic Anemia Trial in Moscow (ICL670, Chelation, No chelation)

Terminated
Has Results
  • Aplastic Anemia
  • Moscow, Russian Federation
    Novartis Investigative Site
Jul 8, 2019

Transfusion-dependent Hemachromatosis, Thalassemia Major, Sickle Cell Disease Trial in Boston (Deferoxamine, Deferasirox, HIDA)

Completed
Has Results
  • Transfusion-dependent Hemachromatosis
  • +2 more
  • Boston, Massachusetts
    Children's Hospital Boston
Jun 14, 2019

Transfusion-dependent ß-thalassemia Patients, Cardiac Iron Overload Trial in Athens, Patras (Deferasirox, Deferoxamine (DFO))

Terminated
Has Results
  • Transfusion-dependent β-thalassemia Patients
  • Cardiac Iron Overload
  • Athens, GR, Greece
  • +3 more
Oct 21, 2019

MDS Trial in Italy (Deferasirox)

Unknown status
  • Myelodysplastic Syndromes
  • Firenze, FI, Italy
  • +9 more
Jul 15, 2019

Thalassemia Major With Severe Transfusional Iron Overload Trial in Chicago, Philadelphia (Deferasirox and deferiprone)

Completed
Has Results
  • Thalassemia Major With Severe Transfusional Iron Overload
  • Deferasirox and deferiprone
  • Chicago, Illinois
  • +1 more
Feb 13, 2019

Acute Myeloblastic Leukemia and Myelodysplastic Syndrome

Unknown status
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • EXJADE
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud
Sep 3, 2018

MDS Trial in Worldwide (Deferasirox, Placebo)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Anaheim, California
  • +71 more
Oct 30, 2020

Liver Fibrosis in Sickle Cell Disease

Completed
  • Sickle Cell Disease
  • Liver transient elastography (Fibroscan)
  • +2 more
  • Miami, Florida
    University of Miami
May 21, 2021

MDS Trial in Toronto (Deferasirox + Azacitidine, Azacitidine)

Terminated
  • Myelodysplastic Syndromes
  • Toronto, Ontario, Canada
    Odette Cancer Centre, Sunnybrook Health Sciences Centre
Apr 24, 2018

Breast Cancer, Iron Overload, Leukemia Trial in Minneapolis (deferasirox)

Terminated
Has Results
  • Breast Cancer
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Dec 3, 2017

Sickle Cell Anemia Trial (Hydroxyurea)

Terminated
Has Results
  • Sickle Cell Anemia
  • (no location specified)
Jul 9, 2020

MDS Trial in Belgium, France (Deferasirox, Vitamin D and Azacitidine)

Unknown status
  • MDS
  • Deferasirox, Vitamin D and Azacitidine
  • Gent, Belgium
  • +14 more
Jan 9, 2018

Hemochromatosis, MDS Trial in Bergen (Deferasirox, Venesection)

Terminated
  • Hemochromatosis
  • Myelodysplastic Syndromes
  • Bergen, Norway
    Haukeland University Hospital, Clinical Trial Unit
Jan 20, 2017

Anemia, Sickle Cell, Transfusion Hemosiderosis Trial in Los Angeles (deferasirox)

Terminated
Has Results
  • Anemia, Sickle Cell
  • Transfusion Hemosiderosis
  • Los Angeles, California
    Childrens Hospital Los Angeles
Dec 15, 2016

Hemoglobinopathies, MDS, Other Inherited or Acquired Anaemia Trial in Australia (deferasirox)

Completed
  • Hemoglobinopathies
  • +6 more
  • Adelaide, Australia
  • +3 more
Feb 20, 2017

Beta Thalassemia Major Anemia Trial in Cairo. (Metformin)

Unknown status
  • Beta Thalassemia Major Anemia
  • Cairo., Egypt
  • +1 more
Jul 16, 2018